يعرض 1 - 10 نتائج من 34 نتيجة بحث عن '"Lymphoid::Leukemia"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Carbo-Meix A, Grau M Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Guijarro F, Frigola G Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Hematopathology Section, Pathology Laboratory, Hospital Clínic de Barcelona, Barcelona, Spain. Wang L Hematopathology Section, Pathology Laboratory, Hospital Clínic de Barcelona, Barcelona, Spain. Royo R Barcelona Supercomputing Center (BSC), Barcelona, Spain. Vela D Hematologia Clínica, Hospital General de Granollers, Granollers, Spain, Hospital General de Granollers

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Haematologica;109(2); https://doi.org/10.3324/haematol.2023.283209Test; Carbo-Meix A, Guijarro F, Wang L, Grau M, Royo R, Frigola G, et al. BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases. Haematologica. 2024 Feb 1;109(2):493-508.; https://hdl.handle.net/11351/11014Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Chatzikonstantinou T, Minga E, Chamou D Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Scarfò L Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy. Karakatsoulis G Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Department of Mathematics, University of Ioannina, Ioannina, Greece. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: eClinicalMedicine;65; https://doi.org/10.1016/j.eclinm.2023.102307Test; Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. eClinicalMedicine. 2023 Nov;65:102307.; https://hdl.handle.net/11351/10847Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Abrisqueta P, Iacoboni G, Serna A, Cabirta A, Bosch F Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Nadeu F Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. Bosch-Schips J Department of Pathology, Hospital Universitari de Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancer Treatment Reviews;120; https://doi.org/10.1016/j.ctrv.2023.102619Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01392; Abrisqueta P, Nadeu F, Bosch-Schips J, Iacoboni G, Serna A, Cabirta A, et al. From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia. Cancer Treat Rev. 2023 Nov;120:102619.; https://hdl.handle.net/11351/10286Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Loscertales J Hematology Department, Hospital Universitario de la Princesa, Madrid, Spain. Abrisqueta-Costa P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gutierrez A Hematology Department, Hospital Son Espases/IdISBa, Palma de Mallorca, Spain. Hernández-Rivas JÁ Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain. Andreu-Lapiedra R Hematology Department, Hospital Universitario La Fe, Valencia, Spain. Mora A Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;15(16); https://doi.org/10.3390/cancers15164047Test; Loscertales J, Abrisqueta-Costa P, Gutierrez A, Hernández-Rivas JÁ, Andreu-Lapiedra R, Mora A, et al. Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers. 2023 Aug 10;15(16):4047.; https://hdl.handle.net/11351/10202Test

  5. 5
    دورية أكاديمية

    المساهمون: Grau M Molecular Pathology of Lymphoid Neoplasms, Fundació Clínic per a la Recerca Biomèdica - Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. López C, Navarro A, Clot G Molecular Pathology of Lymphoid Neoplasms, Fundació Clínic per a la Recerca Biomèdica - Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Universitat de Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain. Frigola G Hematopathology Section, Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain. Nadeu F Molecular Pathology of Lymphoid Neoplasms, Fundació Clínic per a la Recerca Biomèdica - Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain. Vicente Folch L Servei d’Hematologia, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Blood Advances;7(14); https://doi.org/10.1182/bloodadvances.2022009415Test; Grau M, López C, Navarro A, Clot G, Frigola G, Nadeu F, et al. Unraveling the genetics of transformed splenic marginal zone lymphoma. Blood Adv. 2023 Jul 25;7(14):3695-3709.; https://hdl.handle.net/11351/10163Test

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Mansouri L, Thorvaldsdottir B, Sutton LA Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Karakatsoulis G Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece. Department of Mathematics, University of Ioannina, Ioannina, Greece. Meggendorfer M MLL Munich Leukemia Laboratory, Munich, Germany. Parker H Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Bosch F, Tazón-Vega B Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

    العلاقة: Leukemia;37(2); https://doi.org/10.1038/s41375-022-01802-yTest; info:eu-repo/grantAgreement/EC/H2020/739593; Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):339–47.; https://hdl.handle.net/11351/9508Test; 000920775400001

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Muntañola A Department of Hematology, Hospital Universitari Mutua Terrassa, Terrassa, Spain. Arguiñano-Pérez JM Department of Hematology, Hospital Universitario de Navarra, Pamplona, Spain. Dávila J Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain. de Villambrosia SG Department of Hematology, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain. Carpio C Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Jiménez-Ubieto A Department of Hematology, Hospital 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Science;16(2); https://doi.org/10.1111/cts.13450Test; Muntañola A, Arguiñano‐Pérez JM, Dávila J, González de Villambrosia S, Carpio C, Jiménez‐Ubieto A, et al. Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting. Clin Transl Sci. 2023 Feb;16(2):305–12.; https://hdl.handle.net/11351/9524Test; 000890135800001

  8. 8
    تقرير

    المساهمون: Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut; Programa d'Harmonització Farmacoterapèutica. Tractament de la leucèmia limfocítica crònica: informe d’avaluació de resultats. Barcelona: Servei Català de la Salut; 2023.; https://hdl.handle.net/11351/10729Test

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Nadeu F, Playa-Albinyana H, Duran-Ferrer M Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Royo R Barcelona Supercomputing Center (BSC), Barcelona, Spain. Massoni-Badosa R CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Garcia-Torre B Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Abrisqueta P, Castellví J, Bosch F Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

    العلاقة: Nature Medicine;28; https://doi.org/10.1038/s41591-022-01927-8Test; Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022 Aug;28:1662–71.; https://hdl.handle.net/11351/9338Test

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ramos-Campoy S, Puiggros A Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain. Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. Beà S, Costa D Hematopathology Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain. Bougeon S Oncogenomic Laboratory, Hematology Service, Lausanne University Hospital, Lausanne, Switzerland. Larráyoz MJ Cytogenetics and Hematological Genetics Services, Department of Genetics, University of Navarra, Pamplona, Spain. Ortega M, Bosch F Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Haematologica;107(3); https://doi.org/10.3324/haematol.2020.274456Test; Ramos-Campoy S, Puiggros A, Beà S, Bougeon S, Larráyoz MJ, Costa D, et al. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients. Haematologica. 2022 Mar;107(3):593–603.; https://hdl.handle.net/11351/9548Test; 000811240400039